Original Article
Increase in the Incidence of Differentiated Thyroid Carcinoma in Children, Adolescents, and Young Adults: A Population-Based Study

Portions of the study were presented as a poster at the meeting of the American Society of Clinical Oncology, Chicago, IL, June 1-5, 2012.
https://doi.org/10.1016/j.jpeds.2014.01.059Get rights and content

Objective

To investigate trends in incidence of differentiated thyroid carcinomas among children and adolescents and young adults.

Study design

In this ecological time-trends study, we selected cases of differentiated thyroid carcinomas (1984-2010) in patients <30 years from Surveillance, Epidemiology, and End Results 9 cancer registries by using International Classification of Diseases for Oncology, 3rd edition, codes for papillary and follicular cancers. Patients with multiple other primary diseases before differentiated thyroid carcinomas were excluded. SEER*Stat software, version 8.0.4 (National Cancer Institute, Bethesda, Maryland) was used to calculate age-standardized rates (estimated per 1 000 000/persons) and annual percentage changes (APCs) were calculated by the Joinpoint model (Joinpoint software, version 4.0.4; National Cancer Institute).

Results

Rates ranged from 2.77 (1990) to 9.63 (2009) and from 18.35 (1987) to 50.99 (2009), for male and female subjects, respectively. A significant increasing trend in incidence was observed for both male (APC 3.44; 95% CI 2.60-4.28) and female (APC 3.81; 95% CI 3.38-4.24) patients. When a stratified analysis on the basis of tumor size was performed, significant increasing trends were noted for the following categories: <0.5 cm (females: APC 5.09, 95% CI 3.54-6.65), 0.5-0.9 cm (females: APC 8.45, 95% CI 7.09-9.82), 1.0-1.9 cm (males: APC 5.09, 95% CI 3.20-7.01; females: APC 3.42, 95% CI 2.78-4.07), and ≥2 cm (males: APC 2.62, 95% CI 1.64-3.60; females: APC 2.96, 95% CI 2.34-3.59).

Conclusions

Incidence rates for differentiated thyroid carcinomas are increasing among children and adolescents and young adults in the US. The increasing trends for larger tumors rules out diagnostic scrutiny as the only explanation for the observed results. Environmental, dietary, and genetic influences should be investigated.

Section snippets

Methods

We selected cases of differentiated thyroid cancer diagnosed between 1984 and 2010 in patients <30 years of age from the National Cancer Institute's SEER 9 cancer registry (SEER*Stat Database: Incidence - SEER 9 Regs Research Data, Nov 2012 Sub [1973-2010] <Katrina/Rita Population Adjustment> - Linked To County Attributes - Total US, 1969-2011 Counties, National Cancer Institute, Division of Cancer Control and Population Sciences, Surveillance Research Program, Surveillance Systems Branch,

Results

Our series consisted of 6065 patients (5101 women) up to 29 years of age with differentiated thyroid carcinoma; 83.9% of cases occurred in white patients, and 96.8% occurred in adolescents and young adults (Table I). As reported in adult studies, incidence was lower in black patients (5.89 per million people vs 18.83 in white subjects). Tumors measuring 2.0 cm or more accounted for more than 50% of all tumors diagnosed in all age groups. There was an association between tumor size and age;

Discussion

Studies have shown an increase in the incidence of thyroid carcinoma in recent decades15, 16, 17, 18, 19, 20, 21; this increase does not appear to be geographically dependent.19 In this study we sought to investigate whether those same trends are seen at younger age through a population-based analysis encompassing the pediatric and older age groups. Although no changes in incidence trends were seen in children, similar trends seen in adults are occurring in adolescents and young adults.

To

References (34)

  • W. Hung et al.

    Current controversies in the management of pediatric patients with well-differentiated nonmedullary thyroid cancer: a review

    Thyroid

    (2002)
  • N. Besic et al.

    Prognostic factors in follicular carcinoma of the thyroid: a multivariate survival analysis

    Eur J Oncol

    (1999)
  • L.M. McGregor et al.

    Follicle-derived thyroid cancer in young people: the Duke experience

    Pediatr Hematol Oncol

    (2001)
  • K.D. Newman et al.

    Differentiated thyroid cancer: determinants of disease progression in patients <21 years of age at diagnosis: a report from the Surgical Discipline Committee of the Children's Cancer Group

    Ann Surg

    (1998)
  • A.J. Alessandri et al.

    Age is the major determinant of recurrence in pediatric differentiated thyroid carcinoma

    Med Pediatr Oncol

    (2000)
  • L. Berstein et al.

    Carcinomas and other malignant epithelial neoplasms

  • R. Vassilopoulou-Sellin et al.

    Differentiated thyroid cancer in children and adolescents: clinical outcome and mortality after long-term follow-up

    Head Neck

    (1998)
  • Cited by (185)

    • Comparing ATA guidelines vs TI-RADS for evaluation of pediatric thyroid lesions

      2023, International Journal of Pediatric Otorhinolaryngology
    • Pediatric thyroid cancer: Recent developments

      2023, Best Practice and Research: Clinical Endocrinology and Metabolism
    View all citing articles on Scopus

    L.V. was recipient of a scholarship from the program “Pesquisadores do Futuro”- Faculty of Medicine Sciences of Santa Casa of São Paulo, Brazil. The authors declare no conflicts of interest.

    View full text